Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for "Asthma Therapeutics". The market assessment is performed through standard and the tailored research methodology approach.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Asthma Therapeutics Market by Route of Administration

  • Parenteral
  • Inhalation
  • Oral

6 Asthma Therapeutics Market by Drug Class

  • Bronchodilators
  • Mast cell stabilizers
  • Anti-inflammatory
  • Immunosuppressants
  • Combination therapies
  • Leukotriene antagonists

7 Asthma Therapeutics Market by Product

  • Nebulizers
  • Inhalers

8 Geographical Segmentation

9 Vendor Landscaping

10 Company Profiles

  • Roche Diagnostics
  • Sanofi-Aventis SA
  • AstraZeneca
  • Merck & Co., Inc.
  • CareFusion Corporation
  • Boehringer Ingelheim
  • Teva Pharmaceutical Industries Ltd.
  • Sunovion Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche
  • Philips Healthcare
  • GSK
  • GlaxoSmithKline Plc
  • Mitsubishi Tanabe Pharma Corporation
  • Pearl Therapeutics
  • Pulmagen Therapeutics
  • Dynavax Technologies Corp.
  • Array BioPharma
  • SAMA Pharmaceuticals
  • Sterna Biologicals
  • Regeneron Pharmaceuticals

For more information about this report visit http://www.researchandmarkets.com/research/vwgxfr/global_asthma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Asthma Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Asthma Drugs